Previous close | 29.40 |
Open | 29.46 |
Bid | 29.31 x N/A |
Ask | 29.46 x N/A |
Day's range | 29.37 - 29.46 |
52-week range | 26.81 - 38.56 |
Volume | |
Avg. volume | 2,331 |
Market cap | 114.255B |
Beta (5Y monthly) | 0.23 |
PE ratio (TTM) | 22.42 |
EPS (TTM) | 1.31 |
Earnings date | 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 02 June 2022 |
1y target est | N/A |
Earnings preview of key companies reporting next week and what to look out for.
BioNTech (BNTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
On BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its pipeline development now that the pandemic is over.